Form 4 for CRL Charles River Laboratories
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-27 · accession 0001127602-22-016060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-31 | 2022-05-27 | CRL | Creamer Victoria L | EVP, CHRO | A - Grant | $0.00 | +1,493 | 11.3K | +15% | $0 |
| DM | 2022-05-31 | 2022-05-28+ | CRL | Creamer Victoria L | EVP, CHRO | F - Tax | $244.41 | -304 | 11.0K | -3% | -$74.3K |
| D | 2022-05-31 | 2022-05-27 | CRL | Creamer Victoria L | EVP, CHRO | A - Grant | $244.41 | +4,036 | 4,036 | New | +$986.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | A | A | 1,493 | $0.00 | 11,263 | D | — | — | (F1) Unvested restricted stock units vest as follows: 373 on May 27, 2023, 373 on May 27, 2024, 373 on May 27, 2025 and 374 on May 27, 2026. |
| 2 | Common | Common Stock | 2022-05-28 | F | D | 114 | $244.41 | 11,149 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-29 | F | D | 190 | $244.41 | 10,959 | D | — | — | |
| 4 | Derivative | Stock Options (Right to Buy) | 2022-05-27 | A | A | 4,036 | $244.41 | 4,036 | D | $244.41 · 2023-05-27 to 2032-05-27 | 4,036 Common Stock | (F2) Stock Options vest as follows: 1,009 on May 27, 2023, 1,009 on May 27, 2024, 1,009 on May 27, 2025 and 1,009 on May 27, 2026. |